Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUVIA-AF3: Virtual AAD Test in Recurrent AF
NCT04223310Unknown
- Sponsor
- Yonsei University
- Start
- Jun 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Yonsei University. Primary endpoints: Clinical recurrence rate at 24 months and Major cardiovascular event rate at 24 months. Status: unknown.
Beyond the preview
Go deeper on NCT04223310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04223310.